Amit Tirosh1,2, Ilan Shimon3,4. 1. Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, 49100, Israel. 2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 3. Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, 49100, Israel. ilanshi@clalit.org.il. 4. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ilanshi@clalit.org.il.
Abstract
INTRODUCTION: In acromegaly the long-term exposure to high growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels may result in specific complications in different human organs, including the thyroid gland and the colon. MATERIALS AND METHODS: We will review here the evidence available regarding the characteristic thyroid and colon complications in acromegaly. RESULTS: This review summarizes the published data observing noncancerous structural abnormalities (thyroid nodules, colonic polyps) and thyroid and colon cancer in patients diagnosed with acromegaly. CONCLUSION: Thyroid micro-carcinomas are probably over-diagnosed among acromegalic patients. In regard to colon cancer, there is no sufficient data to suggest that colon cancer risk is higher in acromegaly compared to the general population.
INTRODUCTION: In acromegaly the long-term exposure to high growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels may result in specific complications in different human organs, including the thyroid gland and the colon. MATERIALS AND METHODS: We will review here the evidence available regarding the characteristic thyroid and colon complications in acromegaly. RESULTS: This review summarizes the published data observing noncancerous structural abnormalities (thyroid nodules, colonic polyps) and thyroid and colon cancer in patients diagnosed with acromegaly. CONCLUSION: Thyroid micro-carcinomas are probably over-diagnosed among acromegalicpatients. In regard to colon cancer, there is no sufficient data to suggest that colon cancer risk is higher in acromegaly compared to the general population.
Authors: M J E Wassenaar; M Cazemier; N R Biermasz; A M Pereira; F Roelfsema; J W A Smit; D W Hommes; R J F Felt-Bersma; J A Romijn Journal: J Clin Endocrinol Metab Date: 2010-03-09 Impact factor: 5.958
Authors: P Razzore; A Colao; R Baldelli; D Gaia; P Marzullo; E Ferretti; D Ferone; M L Jaffrain-Rea; G Tamburrano; G Lombardi; F Camanni; E Ciccarelli Journal: Clin Endocrinol (Oxf) Date: 1999-08 Impact factor: 3.478
Authors: B Tode; M Serio; C M Rotella; G Galli; F Franceschelli; A Tanini; R Toccafondi Journal: J Clin Endocrinol Metab Date: 1989-09 Impact factor: 5.958
Authors: Sven Berkmann; Javier Fandino; Beat Müller; Karl F Kothbauer; Christoph Henzen; Hans Landolt Journal: Swiss Med Wkly Date: 2012-10-01 Impact factor: 2.193
Authors: P H Geelhoed-Duijvestijn; F Roelfsema; J P Schröder-van der Elst; J van Doorn; D van der Heide Journal: J Endocrinol Date: 1992-04 Impact factor: 4.286
Authors: Margaret C S Boguszewski; Cesar L Boguszewski; Wassim Chemaitilly; Laurie E Cohen; Judith Gebauer; Claire Higham; Andrew R Hoffman; Michel Polak; Kevin C J Yuen; Nathalie Alos; Zoltan Antal; Martin Bidlingmaier; Beverley M K Biller; George Brabant; Catherine S Y Choong; Stefano Cianfarani; Peter E Clayton; Regis Coutant; Adriane A Cardoso-Demartini; Alberto Fernandez; Adda Grimberg; Kolbeinn Guðmundsson; Jaime Guevara-Aguirre; Ken K Y Ho; Reiko Horikawa; Andrea M Isidori; Jens Otto Lunde Jørgensen; Peter Kamenicky; Niki Karavitaki; John J Kopchick; Maya Lodish; Xiaoping Luo; Ann I McCormack; Lillian Meacham; Shlomo Melmed; Sogol Mostoufi Moab; Hermann L Müller; Sebastian J C M M Neggers; Manoel H Aguiar Oliveira; Keiichi Ozono; Patricia A Pennisi; Vera Popovic; Sally Radovick; Lars Savendahl; Philippe Touraine; Hanneke M van Santen; Gudmundur Johannsson Journal: Eur J Endocrinol Date: 2022-04-21 Impact factor: 6.558
Authors: Lisa B Nachtigall; Francisco J Guarda; Kate E Lines; Alireza Ghajar; Laura Dichtel; Giselle Mumbach; Wenxiu Zhao; Xun Zhang; Nicholas A Tritos; Brooke Swearingen; Karen K Miller; Rajesh V Thakker Journal: J Clin Endocrinol Metab Date: 2020-06-01 Impact factor: 5.958